Acorda Multiple Sclerosis Drug Patents Are Invalid, Federal Circuit Affirms

Mealey's (September 11, 2018, 2:23 PM EDT) -- WASHINGTON, D.C. — In a divided Sept. 10 holding, the Federal Circuit U.S. Court of Appeals upheld findings by a Delaware federal judge that four Acorda Therapeutics Inc. patents relating to...
To view the full article, register now.